p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Beat Schafer Felix K Niggli |
| Publication date | May 10, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |